ACM
TENX icon

ADAR1 Capital Management’s Tenax Therapeutics TENX Stock Holding History

ADAR1 Capital Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Buy
220,462
+7,000
+3% +$89.4K 0.15% 125
2026
Q1 		$3.41M Buy
213,462
+149,789
+235% +$2.03M 0.2% 100
2025
Q4 		$776K Buy
63,673
+10,245
+19% +$89.1K 0.06% 154
2025
Q3 		$407K Sell
53,428
-102,129
-66% -$624K 0.04% 149
2025
Q2 		$896K Buy
155,557
+86,816
+126% +$502K 0.14% 91
2025
Q1 		$450K Buy
68,741
+34,048
+98% +$218K 0.08% 112
2024
Q4 		$215K Sell
34,693
-27,730
-44% -$135K 0.04% 154
2024
Q3 		$216K Buy
+62,423
New +$226K 0.04% 158

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ADAR1 Capital Management's TENX Position: Q2 2026 in Review

ADAR1 Capital Management increased its Tenax Therapeutics (TENX) stake by 3.3% in Q2 2026, buying an estimated $89.4K and bringing the position to 220,462 shares worth $3.21M. The position accounts for 0.15% of the portfolio, ranked #125.

ADAR1 Capital Management first reported a position in TENX in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.41M in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • ADAR1 Capital Management held 220,462 shares of Tenax Therapeutics worth $3.21M as of Q2 2026.
  • ADAR1 Capital Management bought 7,000 Tenax Therapeutics shares in Q2 2026, an estimated $89.4K.
  • Tenax Therapeutics made up 0.15% of ADAR1 Capital Management's portfolio in Q2 2026, its #125 holding.
  • ADAR1 Capital Management first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • ADAR1 Capital Management's Tenax Therapeutics position peaked at $3.41M in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.